Search Results - Besterman, J.M.

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    312 A Novel Assay for the Met Inhibitory Activity of MGCD265 in Plasma From Solid Tumor Patients in a Dose Escalating Phase I Study

    312 A Novel Assay for the Met Inhibitory Activity of MGCD265 in Plasma From Solid Tumor Patients in a Dose Escalating Phase I Study by Fournel, M, Wang, J, Beaulieu, N, Bonfils, C, Hurwitz, H, Shapiro, G, Kollmannsberger, C.K, Juretic, M, Besterman, J.M, Maroun, C.R

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

    Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens by Pfaller, M.A, Messer, S.A, Georgopapadakou, N, Martell, L.A, Besterman, J.M, Diekema, D.J

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Mammalian DNA ligase II is highly homologous with vaccinia DNA ligase. Identification of the DNA ligase II active site for enzyme-adenylate formation

    Mammalian DNA ligase II is highly homologous with vaccinia DNA ligase. Identification of the DNA ligase II active site for enzyme-adenylate formation by Wang, Y.C., Burkhart, W.A., Mackey, Z.B., Moyer, M.B., Ramos, W, Husain, I, Chen, J, Besterman, J.M., Tomkinson, A.E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Inhibition of DNA helicase II unwinding and ATPase activities by DNA-interacting ligands. Kinetics and specificity

    Inhibition of DNA helicase II unwinding and ATPase activities by DNA-interacting ligands. Kinetics and specificity by GEORGE, J. W, GHATE, S, MATSON, S. W, BESTERMAN, J. M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    81 POSTER Preclinical pharmacodynamic markers of MGCD265, a potent orally active c-Met/VEGFR multitargeted kinase inhibitor in Phase I clinical trials

    81 POSTER Preclinical pharmacodynamic markers of MGCD265, a potent orally active c-Met/VEGFR multitargeted kinase inhibitor in Phase I clinical trials by Beaulieu, N, Dupont, I, Beaulieu, C, Nguyen, H, Ste-Croix, H, Claridge, S, Isakovic, L, Vaisburg, A, Besterman, J.M, Maroun, C

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Mammalian DNA ligase III: molecular cloning, chromosomal localization, and expression in spermatocytes undergoing meiotic recombination

    Mammalian DNA ligase III: molecular cloning, chromosomal localization, and expression in spermatocytes undergoing meiotic recombination by Chen, Jingwen, Tomkinson, Alan E., Ramos, William, Mackey, Zachary B., Danehower, Sue, Walter, Christi A., Schultz, Roger A., Besterman, Jeffrey M., Husain, Intisar

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Lupane Derivatives from Lophopetalum wallichii with Farnesyl Protein Transferase Inhibitory Activity

    Lupane Derivatives from Lophopetalum wallichii with Farnesyl Protein Transferase Inhibitory Activity by Sturm, Sonja, Gil, Roberto R, Chai, Hee-Byung, Ngassapa, Olipa D, Santisuk, Thawatchai, Reutrakul, Vichai, Howe, Anne, Moss, Marcia, Besterman, Jeffrey M, Yang, Shi-Lin, Farthing, John E, Tait, R. Murray, Lewis, Jane A, O'Neill, Melanie J, Farnsworth, Norman R, Cordell, Geoffrey A, Pezzuto, John M, Kinghorn, A. Douglas

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: